We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

187 hedge funds and large institutions have $1.02B invested in Editas Medicine in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 54

10.1% more ownership

Funds ownership: 80.77% → 90.87% (+10%)

4% more capital invested

Capital invested by funds: $983M → $1.02B (+$40.8M)

3% less funds holding

Funds holding: 193 → 187 (-6)

25% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 24

47% less call options, than puts

Call options by funds: $8.12M | Put options by funds: $15.2M

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
187
Holders Change
-6
Holders Change %
-3.11%
% of All Funds
4.1%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
18
Increased
60
Reduced
54
Closed
24
Calls
$8.12M
Puts
$15.2M
Net Calls
-$7.07M
Net Calls Change
-$888K

Top Buyers

Rank Fund Capital Flow
1
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$85.3M
2
NAMA
Nikko Asset Management Americas
New York
+$45.7M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$16.8M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.78M
5
BlackRock
BlackRock
New York
+$6.24M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16M
2
State Street
State Street
Massachusetts
-$14.2M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$4.9M
4
Citadel Advisors
Citadel Advisors
Florida
-$4.61M
5
WCM
Wildcat Capital Management
New York
-$4.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.8M +$759K +30,646 +11%
SBH
27
Segall Bryant & Hamill
Illinois
$5.85M -$336K -13,550 -5%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$5.69M +$1.05M +42,580 +20%
Deutsche Bank
29
Deutsche Bank
Germany
$5.62M -$1.12M -45,399 -16%
UBS Group
30
UBS Group
Switzerland
$5.41M +$2.98M +120,159 +102%
N
31
Nuveen
North Carolina
$4.75M +$622K +25,097 +14%
Victory Capital Management
32
Victory Capital Management
Texas
$4.58M +$4.99M +201,340 New
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$4.39M -$1.92M -77,463 -29%
CAI
34
Capital Advisors Inc
Oklahoma
$3.39M – – –
TCM
35
Tekla Capital Management
Massachusetts
$3.36M +$2.55M +102,950 +229%
Citadel Advisors
36
Citadel Advisors
Florida
$2.97M -$4.61M -186,315 -59%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$2.62M -$773K -31,188 -21%
Citigroup
38
Citigroup
New York
$2.2M +$1.07M +42,997 +80%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$2.12M +$820K +33,100 +55%
QI
40
QS Investors
New York
$2.11M – – –
HAM
41
HHR Asset Management
New Jersey
$2.1M – – –
Fidelity Investments
42
Fidelity Investments
Massachusetts
$2.09M -$16M -647,406 -88%
PP
43
PDT Partners
New York
$2.08M -$1.19K -48 -0.1%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.89M +$76.8K +3,100 +4%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.76M +$22.9K +923 +1%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$1.69M +$126K +5,100 +7%
Ameriprise
47
Ameriprise
Minnesota
$1.62M +$434K +17,522 +33%
AllianceBernstein
48
AllianceBernstein
Tennessee
$1.5M – – –
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$1.5M -$2.3K -93 -0.1%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$1.49M +$5.92K +239 +0.4%
1
2
3 4 5

EDIT Hedge Fund Activity: Q3 2019 in Review

187 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2019, worth a combined $1.02B — up 4.1% from $983M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of EDIT and 18 opened new positions — a net loss of 6 holders — while 54 trimmed existing stakes and 60 added.

The largest buyer was Sumitomo Mitsui Trust Group, adding an estimated $85.3M. The largest seller was Fidelity Investments, cutting an estimated $16M.

  • 187 institutional investors held Editas Medicine (EDIT) as of Q3 2019, down from 193 in Q2 2019.
  • Funds reported $1.02B of Editas Medicine stock for Q3 2019, up 4.1% quarter-over-quarter.
  • 18 funds opened new Editas Medicine positions in Q3 2019 and 24 closed out, a net change of -6 holders.
  • The largest Editas Medicine buyer in Q3 2019 was Sumitomo Mitsui Trust Group, an estimated $85.3M added.
  • The largest Editas Medicine seller in Q3 2019 was Fidelity Investments, an estimated $16M sold.

Based on aggregated 13F filings for Q3 2019.